<DOC>
	<DOCNO>NCT01735786</DOCNO>
	<brief_summary>Endoscopic mucosal resection ( EMR ) widely use diagnostic treatment technique gastrointestinal small lesion . Postoperative rebleeding one common complication follow EMR . Several endoscopic hemostasis method currently use . EndoClotÂ® absorbable polysaccharide hemostat ( PAPH ) new hemostasis material previously use surgical hemostasis , therapeutic effect safety endoscopic application remain unknown . This study design observe effect rebleeding prevention EMR .</brief_summary>
	<brief_title>EndoClot Preventing Rebleeding After Endoscopic Mucosal Resection ( EMR )</brief_title>
	<detailed_description />
	<mesh_term>Colonic Polyps</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>consecutive case colorectal polyp submucosal lesion anticipate complete removal endoscopically EMR . severe cardiovascular disease , liver kidney dysfunction ; platelet coagulation dysfunction ( PLT &lt; 50*109/L , INR &gt; 2 ) ; case take anticoagulant drug nonsteroidal antiinflammatory drug within 1 month procedure ; case unavailable followup .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Endoscopic Hemostasis</keyword>
	<keyword>EndoClot Absorbable Polysaccharide Hemostat</keyword>
	<keyword>Colonic Polyps</keyword>
</DOC>